June 24, 2020 / 7:59 PM / 12 days ago

BRIEF-Reata Pharmaceuticals Announces Receipt Of $350 Mln Related To Closing Of Previously Announced Strategic Investment

June 24 (Reuters) - Reata Pharmaceuticals Inc:

* REATA PHARMACEUTICALS - ANNOUNCED RECEIPT OF $350 MILLION RELATED TO CLOSING OF PREVIOUSLY ANNOUNCED STRATEGIC INVESTMENT

* REATA PHARMACEUTICALS - FINANCING INCLUDES $300 MILLION IN RETURN FOR SINGLE-DIGIT ROYALTY PAYMENTS ON WORLDWIDE NET SALES OF BARDOXOLONE METHYL

* REATA PHARMACEUTICALS - FINANCING ALSO INCLUDES $50 MILLION INVESTMENT IN 340,793 SHARES OF CO'S CLASS A COMMON STOCK AT $146.72/SHARE Source text: (bit.ly/2Z92UqT) Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below